Industry Perspectives - Design & Development
-
Conducting A Medical Device Stability Study: A Practical Guide
1/7/2026
Stability studies measure how medical devices respond to environmental stresses such as temperature, humidity, light, and time. Let's take a closer look at designing and conducting a stability study.
-
Reimagining HACCP And Other Process Flow Risk Analysis Methods Using Relational Risk Analysis
12/17/2025
Combining relational risk analysis (ReRA) modeling strategies with hazard analysis and critical control point (HACCP) and other process flow risk analysis methods makes them more efficient.
-
Maximizing The Value Of An Internal Audit Program In Pharmaceutical Quality Operations
11/18/2025
A shrinking FDA and rising supply pressures demand stronger risk management and smarter internal audits. Here’s how pharma can truly “see things as they really are.”
-
Building World-Class Global Quality Teams That Break Down Silos
11/10/2025
Over 25 years leading global quality and regulatory organizations, I've learned that the most difficult challenges aren't regulatory or technical; they're organizational and cultural.
-
Mastering Cultural Intelligence In Global Quality And Regulatory Leadership
11/5/2025
The medical device industry has gone global, but most quality and regulatory leaders still operate with regional mindsets. Leaders who master cultural intelligence build quality systems that leverage diversity as competitive advantage.
-
A Better Interpretation Of POH In ISO 24971
11/3/2025
Probability of harm (POH) is critical to appropriately scoring risks, so how should it be done? POH needs to show all probabilities, not suppress them.
-
Why Pharmaceutical And Medical Device Risks Must Be Analyzed By Their Risk Mechanisms
9/16/2025
Current risk analysis methods focus on the possibility and severity of bad events instead of focusing directly on analyzing and improving the performance of systems and processes producing the bad events.
-
Improving Drug-Device Combination Product Co-Development
8/8/2025
Early recognition and mitigation of drug and device integration difficulties are critical to the success of combination products. The collaborative effort in development cannot be overstated.
-
Minimizing The Impact Of Human Errors Using Relational Risk Analysis
8/4/2025
This article describes how a mechanism-based risk analysis approach can provide two complementary opportunities for minimizing the likelihood of a human error impacting pharmaceutical and medical device risks.
-
Process Validation: Optimizing Operational Excellence In Pharma And Medical Devices
7/3/2025
Process validation is often viewed as a costly regulatory formality. However, it is actually a strategic investment that, when integrated into business planning, delivers measurable outcomes in productivity, compliance, speed-to-market, and profitability.